Skip to content

Comparison of the Effects of Aerobic Exercise and Connective Tissue Massage in Postpartum Women

Comparison of the Effects of Aerobic Exercise and Connective Tissue Massage in Postpartum Women

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05721625
Enrollment
40
Registered
2023-02-10
Start date
2023-02-15
Completion date
2024-02-15
Last updated
2023-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Women

Keywords

sleep, depression, massage, exercise

Brief summary

The aim of this study is to compare the effects of aerobic exercise and connective tissue massage on sleep, mother-infant attachment and psychological state in postpartum women.

Detailed description

Postpartum period can affect the mental and physical health of women. Women may experience sleep problems and psychological problems due to hormonal changes and newborn care responsibilities. As a result, mother-infant attachment may also be affected. Physical activity and exercise should be encouraged in the postpartum period. It is known that aerobic exercises have positive effects on sleep and psychological problems. With the effects of connective tissue massage on the autonomic and circulatory system in the body, positive effects on sleep and psychological state can be achieved, but there are insufficient studies on this subject. In addition, no study has been found to the best of our knowledge comparing the effects of aerobic exercise and connective tissue massage in postpartum women.

Interventions

OTHERAerobic exercise

The aerobic exercise program will be applied at moderate intensity 3 days a week for 8 weeks. Walking will be recommended as an aerobic exercise

Connective tissue massage will be applied by the physiotherapist 3 days a week for 8 weeks. While the patients are in the sitting position, this massage will be applied on whole back.

Sponsors

Ankara Yildirim Beyazıt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Postpartum 6th week-1 year * Between the ages of 18-45 * Being literate

Exclusion criteria

* Those with orthopedic, neurological, rheumatological, mental or any systemic chronic diseases * Those with cardiac problems that may interfere with exercise * Those with suspected pregnancy * Those with malignancy * Those who have infection * Those who do not regularly participate in the treatment program

Design outcomes

Primary

MeasureTime frameDescription
Postpartum Sleep Quality Scalechange from baseline at 8 weeksIn order to measure Postpartum Sleep Quality, Postpartum Sleep Quality Scale will be used. The scale includes 14 items. The lowest score that can be obtained from the scale is 0, and the highest score is 56. An increase in the score indicates a decrease in sleep quality.

Secondary

MeasureTime frameDescription
Mother to Infant Bonding Scalechange from baseline at 8 weeksThe Mother to Infant Bonding Scale, which was developed to be applied to the mother from the first day immediately after birth and allows the mother to express her feelings towards her baby in one word, will be used. This scale consists of 8 items. The lowest score that can be obtained from the scale is 0 and the highest score is 24. As the score obtained from the scale increases, the level of mother-infant attachment decreases.
Edinburgh Postpartum Depression Scalechange from baseline at 8 weeksThe Edinburgh Postpartum Depression Scale, which was prepared for screening purposes to determine the risk of depression in postpartum women, is not intended to diagnose depression. This scale consists of 10 items. The lowest score that can be obtained from the scale is 0 and the highest score is 30. The cut-off point of the scale was calculated as 13, and women with a scale score of 13 or more were considered as the risk group.

Contacts

Primary ContactSeyda Toprak Celenay
sydtoprak@hotmail.com+90312 906 1000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026